Seeking Alpha

Bio-Rad Laboratories (BIO +1.1%) could be a tasty purchase due its low valuation and prudent...

Bio-Rad Laboratories (BIO +1.1%) could be a tasty purchase due its low valuation and prudent management, according to analysts. Chatter on the street sees the life-science equipment maker making a nice "bolt-on" acquisition for either Thermo Fisher (TMO +3.1%) or Life Technologies (LIFE -1.6%).
Comments (1)
  • hechtic
    , contributor
    Comment (1) | Send Message
     
    Don't expect Bio-Rad to be sold any time. It's a family run business and they have no intention to sell despite rumors to the contrary following the death of founder Dave Schwartz.
    27 Apr 2012, 06:49 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs